Ex vivo studies sit between test-tube experiments and full clinical trials on the evidence scale
AHK-Cu is a synthetic copper-binding tripeptide extensively used in pre-clinical research to investigate dermal papilla cell activity, hair follicle biology, angiogenic signaling, and extracellular matrix dynamics in skin models
Who might it be best for Given the mechanism, benefits and limitations, the ideal candidate profile might look like this: Individuals who have stubborn fat (especially visceral/subcutaneous) despite diet/exercise efforts, and want to improve body composition without major muscle loss
The study was published in the peer-reviewed Archives of Pharmacal Research and has been cited by numerous subsequent studies globally
The name describes its molecular structure, a chain of three amino acids bound to a copper ion
Heres a sampling of the cost per injection of some Ive reviewed above